Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heerajnarain Bulluck

Showing results (31-40 of 122) with videos related to

Pageof 13
Sort By:
International Journal of Cardiology|January 3, 2015
Safety of short-term dual antiplatelet therapy after drug-eluting stents: An updated meta-analysis with direct and adjusted indirect comparison of randomized control trialsHeerajnarain Bulluck, Chun Shing Kwok, Alisdair D Ryding, et al.
Thescientificworldjournal|April 12, 2014
Benefits and harms of extending the duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stents: a meta-analysisChun Shing Kwok, Heerajnarain Bulluck, Alisdair D Ryding, et al.
Circulation|May 2, 2018
Cardiovascular Magnetic Resonance in Acute ST-Segment-Elevation Myocardial Infarction: Recent Advances, Controversies, and Future DirectionsHeerajnarain Bulluck, Rohan Dharmakumar, Andrew E Arai, et al.
Conditioning Medicine|March 6, 2020
Is there a role for remote ischemic conditioning in preventing 5-fluorouracil-induced coronary vasospasm?Jun Chong, Andrew Fw Ho, Jonathan Yap, et al.
Conditioning Medicine|April 22, 2020
Chronic remote ischemic conditioning for cardiovascular protectionJun Chong, Heerajnarain Bulluck, Andrew Fw Ho, et al.
JACC. Cardiovascular Imaging|March 11, 2017
Myocardial Infarct Size by CMR in Clinical Cardioprotection Studies: Insights From Randomized Controlled TrialsHeerajnarain Bulluck, Matthew Hammond-Haley, Shane Weinmann, et al.
International Journal of Cardiology|September 25, 2015
Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients: An updated meta-analysis of randomized controlled trialsHeerajnarain Bulluck, Alex Sirker, Yoon K Loke, et al.
International Journal of Cardiology|December 3, 2016
Bioresorbable stents: Current and upcoming bioresorbable technologiesHui Ying Ang, Heerajnarain Bulluck, Philip Wong, et al.
Journal of Clinical Medicine|October 16, 2025
An Updated Meta-Analysis of Randomized Controlled Trials Comparing Direct Oral Anticoagulants Against Warfarin for Left Ventricular Thrombus ResolutionJoseph Magdy, Maggie He, Sacchin Arockiam, et al.
Heart, Lung & Circulation|May 2, 2022
Incidence and Clinical Predictors of Non-Obstructive Coronary Arteries in Patients With Suspected Non-ST Elevation Myocardial Infarction Undergoing Invasive Coronary AngiographyJoshua Michaels, Shane Parfrey, Abdul M Mozid, et al.
Pageof 13

Showing results (31-40 of 122) with videos related to

Sort By:
Pageof 13
International Journal of Cardiology|January 3, 2015
Safety of short-term dual antiplatelet therapy after drug-eluting stents: An updated meta-analysis with direct and adjusted indirect comparison of randomized control trialsHeerajnarain Bulluck, Chun Shing Kwok, Alisdair D Ryding, et al.
Thescientificworldjournal|April 12, 2014
Benefits and harms of extending the duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stents: a meta-analysisChun Shing Kwok, Heerajnarain Bulluck, Alisdair D Ryding, et al.
Circulation|May 2, 2018
Cardiovascular Magnetic Resonance in Acute ST-Segment-Elevation Myocardial Infarction: Recent Advances, Controversies, and Future DirectionsHeerajnarain Bulluck, Rohan Dharmakumar, Andrew E Arai, et al.
Conditioning Medicine|March 6, 2020
Is there a role for remote ischemic conditioning in preventing 5-fluorouracil-induced coronary vasospasm?Jun Chong, Andrew Fw Ho, Jonathan Yap, et al.
Conditioning Medicine|April 22, 2020
Chronic remote ischemic conditioning for cardiovascular protectionJun Chong, Heerajnarain Bulluck, Andrew Fw Ho, et al.
JACC. Cardiovascular Imaging|March 11, 2017
Myocardial Infarct Size by CMR in Clinical Cardioprotection Studies: Insights From Randomized Controlled TrialsHeerajnarain Bulluck, Matthew Hammond-Haley, Shane Weinmann, et al.
International Journal of Cardiology|September 25, 2015
Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients: An updated meta-analysis of randomized controlled trialsHeerajnarain Bulluck, Alex Sirker, Yoon K Loke, et al.
International Journal of Cardiology|December 3, 2016
Bioresorbable stents: Current and upcoming bioresorbable technologiesHui Ying Ang, Heerajnarain Bulluck, Philip Wong, et al.
Journal of Clinical Medicine|October 16, 2025
An Updated Meta-Analysis of Randomized Controlled Trials Comparing Direct Oral Anticoagulants Against Warfarin for Left Ventricular Thrombus ResolutionJoseph Magdy, Maggie He, Sacchin Arockiam, et al.
Heart, Lung & Circulation|May 2, 2022
Incidence and Clinical Predictors of Non-Obstructive Coronary Arteries in Patients With Suspected Non-ST Elevation Myocardial Infarction Undergoing Invasive Coronary AngiographyJoshua Michaels, Shane Parfrey, Abdul M Mozid, et al.
Pageof 13